Suppr超能文献

红核中铁含量升高提示帕金森病异动症。

Higher iron in the red nucleus marks Parkinson's dyskinesia.

机构信息

Department of Neurology, Pennsylvania State University-Milton S. Hershey Medical Center, Hershey, PA 17033-0850, USA.

出版信息

Neurobiol Aging. 2013 May;34(5):1497-503. doi: 10.1016/j.neurobiolaging.2012.10.025. Epub 2012 Nov 21.

Abstract

Dopamine cell loss and increased iron in the substantia nigra (SN) characterize Parkinson's disease (PD), with cerebellar involvement increasingly recognized, particularly in motor compensation and levodopa-induced dyskinesia (LID) development. Because the red nucleus (RN) mediates cerebellar circuitry, we hypothesized that RN iron changes might reflect cerebellum-related compensation, and/or the intrinsic capacity for LID development. We acquired high resolution magnetic resonance images from 23 control and 38 PD subjects (12 with PD and history of LID [PD+DYS]) and 26 with PD and no history of LID (PD-DYS). Iron content was estimated from bilateral RN and SN transverse relaxation rates (R2*). PD subjects overall displayed higher R2* values in both the SN and RN. RN R2* values correlated with off-drug Unified Parkinson's Disease Rating Scale-motor scores, but not disease duration or drug dosage. RN R2* values were significantly higher in PD+DYS compared with control and PD-DYS subjects; control and PD-DYS subjects did not differ. The association of higher RN iron content with PD-related dyskinesia suggests increased iron content is involved in, or reflects, greater cerebellar compensatory capacity and thus increased likelihood of LID development.

摘要

黑质(SN)中的多巴胺细胞丢失和铁含量增加是帕金森病(PD)的特征,小脑受累越来越受到重视,特别是在运动补偿和左旋多巴诱导的运动障碍(LID)发展中。由于红核(RN)介导小脑回路,我们假设 RN 铁变化可能反映与小脑相关的补偿,和/或 LID 发展的内在能力。我们从 23 名对照和 38 名 PD 受试者(12 名 PD 且有 LID 病史 [PD+DYS],26 名 PD 且无 LID 病史 [PD-DYS])中获得了高分辨率磁共振图像。从双侧 RN 和 SN 横向弛豫率(R2*)估算铁含量。PD 受试者的 SN 和 RN 的 R2值均升高。RN R2值与停药后统一帕金森病评定量表-运动评分相关,但与疾病持续时间或药物剂量无关。PD+DYS 受试者的 RN R2*值明显高于对照组和 PD-DYS 受试者;对照组和 PD-DYS 受试者之间没有差异。较高的 RN 铁含量与 PD 相关运动障碍相关,表明铁含量增加参与或反映了更大的小脑补偿能力,从而增加了 LID 发展的可能性。

相似文献

1
Higher iron in the red nucleus marks Parkinson's dyskinesia.
Neurobiol Aging. 2013 May;34(5):1497-503. doi: 10.1016/j.neurobiolaging.2012.10.025. Epub 2012 Nov 21.
3
Quantitative susceptibility mapping of the midbrain in Parkinson's disease.
Mov Disord. 2016 Mar;31(3):317-24. doi: 10.1002/mds.26417. Epub 2015 Sep 12.
4
Multimodal Imaging of Substantia Nigra in Parkinson's Disease with Levodopa-Induced Dyskinesia.
Mov Disord. 2023 Apr;38(4):616-625. doi: 10.1002/mds.29320. Epub 2023 Feb 17.
5
Quantitative Susceptibility Mapping in Parkinson's Disease.
PLoS One. 2016 Sep 6;11(9):e0162460. doi: 10.1371/journal.pone.0162460. eCollection 2016.
7
Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: an in vivo MR study.
Brain Res. 2010 May 12;1330:124-30. doi: 10.1016/j.brainres.2010.03.036. Epub 2010 Mar 18.
8
Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.
Brain. 2011 Jan;134(Pt 1):50-8. doi: 10.1093/brain/awq319. Epub 2010 Nov 24.
9
Association of freezing of gait with nigral iron accumulation in patients with Parkinson's disease.
J Neurol Sci. 2017 Nov 15;382:61-65. doi: 10.1016/j.jns.2017.09.033. Epub 2017 Sep 23.
10
Influence of regional iron on the motor impairments of Parkinson's disease: A quantitative susceptibility mapping study.
J Magn Reson Imaging. 2017 May;45(5):1335-1342. doi: 10.1002/jmri.25434. Epub 2016 Aug 22.

引用本文的文献

2
Gradients of Nigrostriatal Iron Deposition in Healthy Aging and Synucleinopathies.
CNS Neurosci Ther. 2025 Mar;31(3):e70359. doi: 10.1111/cns.70359.
3
Levodopa-induced dyskinesia: brain iron deposition as a new hypothesis.
Biometals. 2024 Dec;37(6):1307-1323. doi: 10.1007/s10534-024-00628-8. Epub 2024 Aug 30.
4
Neuropathological findings and in vivo imaging correlates of the red nucleus compared to those of the substantia nigra pars compacta in parkinsonisms.
Parkinsonism Relat Disord. 2024 Aug;125:107043. doi: 10.1016/j.parkreldis.2024.107043. Epub 2024 Jun 15.
5
Iron deposition in subcortical nuclei of Parkinson's disease: A meta-analysis of quantitative iron-sensitive magnetic resonance imaging studies.
Chin Med J (Engl). 2025 Mar 20;138(6):678-692. doi: 10.1097/CM9.0000000000003167. Epub 2024 May 28.
6
The Iron Metabolism with a Specific Focus on the Functioning of the Nervous System.
Biomedicines. 2024 Mar 6;12(3):595. doi: 10.3390/biomedicines12030595.
7
Spatiotemporal patterns of brain iron-oxygen metabolism in patients with Parkinson's disease.
Eur Radiol. 2024 May;34(5):3074-3083. doi: 10.1007/s00330-023-10283-1. Epub 2023 Oct 19.
10
Comparison between Dual-Energy CT and Quantitative Susceptibility Mapping in Assessing Brain Iron Deposition in Parkinson Disease.
AJNR Am J Neuroradiol. 2023 Apr;44(4):410-416. doi: 10.3174/ajnr.A7822. Epub 2023 Mar 23.

本文引用的文献

2
Metabolic changes induced by theta burst stimulation of the cerebellum in dyskinetic Parkinson's disease patients.
Parkinsonism Relat Disord. 2012 Jan;18(1):59-62. doi: 10.1016/j.parkreldis.2011.08.019. Epub 2011 Sep 15.
3
Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease.
Mov Disord. 2011 Aug 1;26(9):1627-32. doi: 10.1002/mds.23643. Epub 2011 May 26.
4
Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.
Ann Neurol. 2011 May;69(5):803-10. doi: 10.1002/ana.22284. Epub 2011 Jan 18.
5
Internal models in the cerebellum.
Trends Cogn Sci. 1998 Sep 1;2(9):338-47. doi: 10.1016/s1364-6613(98)01221-2.
6
Differential involvement of striato- and cerebello-thalamo-cortical pathways in tremor- and akinetic/rigid-predominant Parkinson's disease.
Neuroscience. 2011 Mar 17;177:230-9. doi: 10.1016/j.neuroscience.2010.12.060. Epub 2011 Jan 4.
7
Systematic review of levodopa dose equivalency reporting in Parkinson's disease.
Mov Disord. 2010 Nov 15;25(15):2649-53. doi: 10.1002/mds.23429.
9
The basal ganglia communicate with the cerebellum.
Proc Natl Acad Sci U S A. 2010 May 4;107(18):8452-6. doi: 10.1073/pnas.1000496107. Epub 2010 Apr 19.
10
The transition metals copper and iron in neurodegenerative diseases.
Chem Biol Interact. 2010 Jul 30;186(2):184-99. doi: 10.1016/j.cbi.2010.04.010. Epub 2010 May 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验